Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 165215, 15 pages
http://dx.doi.org/10.1155/2015/165215
Review Article

The Endocrine Role of Estrogens on Human Male Skeleton

1Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via P. Giardini 1355, 41126 Modena, Italy
2Azienda USL di Modena, Nuovo Ospedale Civile Sant’Agostino Estense (NOCSAE), Via P. Giardini 1355, 41126 Modena, Italy

Received 23 August 2014; Accepted 14 November 2014

Academic Editor: Martina Rauner

Copyright © 2015 Vincenzo Rochira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. C. MacDonald, J. D. Madden, P. F. Brenner, J. D. Wilson, and P. K. Siiteri, “Origin of estrogen in normal men and in women with testicular feminization,” The Journal of Clinical Endocrinology & Metabolism, vol. 49, no. 6, pp. 905–916, 1979. View at Publisher · View at Google Scholar · View at Scopus
  2. E. R. Simpson, M. S. Mahendroo, G. D. Means et al., “Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis,” Endocrine Reviews, vol. 15, no. 3, pp. 342–355, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. W. L. Miller and R. J. Auchus, “The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders,” Endocrine Reviews, vol. 32, no. 1, pp. 81–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Stocco, “Tissue physiology and pathology of aromatase,” Steroids, vol. 77, no. 1-2, pp. 27–35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Enmark and J.-Å. Gustafsson, “Oestrogen receptors—an overview,” Journal of Internal Medicine, vol. 246, no. 2, pp. 133–138, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. C. J. Gruber, W. Tschugguel, C. Schneeberger, and J. C. Huber, “Mechanisms of disease: production and actions of estrogens,” The New England Journal of Medicine, vol. 346, no. 5, pp. 340–352, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Revankar, D. F. Cimino, L. A. Sklar, J. B. Arterburn, and E. R. Prossnitz, “A transmembrane intracellular estrogen receptor mediates rapid cell signaling,” Science, vol. 307, no. 5715, pp. 1625–1630, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. F. Couse and K. S. Korach, “Estrogen receptor null mice: what have we learned and where will they lead us?” Endocrine Reviews, vol. 20, no. 3, pp. 358–417, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Murata, K. M. Robertson, M. E. E. Jones, and E. R. Simpson, “Effect of estrogen deficiency in the male: the ArKO mouse model,” Molecular and Cellular Endocrinology, vol. 193, no. 1-2, pp. 7–12, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Faustini-Fustini, V. Rochira, and C. Carani, “Oestrogen deficiency in men: where are we today?” European Journal of Endocrinology, vol. 140, no. 2, pp. 111–129, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Grumbach and R. J. Auchus, “Estrogen: consequences and implications of human mutations in synthesis and action,” The Journal of Clinical Endocrinology & Metabolism, vol. 84, no. 12, pp. 4677–4694, 1999. View at Google Scholar · View at Scopus
  12. B. J. Deroo and K. S. Korach, “Estrogen receptors and human disease,” Journal of Clinical Investigation, vol. 116, no. 3, pp. 561–570, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Rochira, A. R. M. Granata, B. Madeo, L. Zirilli, G. Rossi, and C. Carani, “Estrogens in males: what have we learned in the last 10 years?” Asian Journal of Andrology, vol. 7, no. 1, pp. 3–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. S. Finkelstein, H. Lee, S.-A. M. Burnett-Bowie et al., “Gonadal steroids and body composition, strength, and sexual function in men,” The New England Journal of Medicine, vol. 369, no. 11, pp. 1011–1022, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. F. W. George and J. D. Wilson, “Sex determination and differentiation,” in The Physiology of Reproduction, E. Knobil and I. J. Neill, Eds., pp. 2–27, Raven Press, New York, NY, USA, 1988. View at Google Scholar
  16. K. Bay, A. M. Andersson, and N. E. Skakkebaek, “Estradiol levels in prepubertal boys and girls—analytical challenges,” International Journal of Andrology, vol. 27, no. 5, pp. 266–273, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Vandewalle, Y. Taes, T. Fiers et al., “Sex steroids in relation to sexual and skeletal maturation in obese male adolescents,” The Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 8, pp. 2977–2985, 2014. View at Google Scholar
  18. S. Vandewalle, Y. Taes, T. Fiers et al., “Associations of sex steroids with bone maturation, bone mineral density, bone geometry, and body composition: a cross-sectional study in healthy male adolescents,” The Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 7, pp. E1272–E1282, 2014. View at Publisher · View at Google Scholar
  19. K. O. Klein, P. M. Martha Jr., R. M. Blizzard, T. Herbst, and A. D. Rogol, “A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. II. Estrogen levels as determined by an ultrasensitive bioassay,” The Journal of Clinical Endocrinology & Metabolism, vol. 81, no. 9, pp. 3203–3207, 1996. View at Google Scholar · View at Scopus
  20. G. B. Cutler Jr., “The role of estrogen in bone growth and a maturation during childhood and adolescence,” Journal of Steroid Biochemistry and Molecular Biology, vol. 61, no. 3–6, pp. 141–144, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Rochira, A. Balestrieri, M. Faustini-Fustini, and C. Carani, “Role of estrogen on bone in the human male: insights from the natural models of congenital estrogen deficiency,” Molecular and Cellular Endocrinology, vol. 178, no. 1-2, pp. 215–220, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Chagin and L. Sävendahl, “Estrogens and growth: review,” Pediatric Endocrinology Reviews, vol. 4, no. 4, pp. 329–334, 2007. View at Google Scholar · View at Scopus
  23. J. Emons, A. S. Chagin, L. Sävendahl, M. Karperien, and J. M. Wit, “Mechanisms of growth plate maturation and epiphyseal fusion,” Hormone Research in Paediatrics, vol. 75, no. 6, pp. 383–391, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Wilkins, “Endocrine relationships and their influences upon growth and development,” in The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence, chapter 2, pp. 10–24, C. C. Thomas, Springfield, Ill, USA, 1950. View at Google Scholar
  25. H. S. Kuppermann, “Male endocrinology: hypogonadism in adolescent male and cryptorchidism,” in Human Endocrinology, H. S. Kuppermann, Ed., Chapter 16, pp. 504–563, Davis Company Publishers, Philadelphia, Pa, USA, 1963. View at Google Scholar
  26. R. M. Blizzard, R. G. Thompson, A. Baghdassarian, A. Kowarski, C. J. Migeon, and A. Rodriguez, “The interrelationship of steroids, growth hormone and other hormones on pubertal growth,” in The Control of the Onset of Puberty, M. M. Grumbach, G. D. Grave, and F. E. Mayer, Eds., p. 342, John Wiley & Sons, New York, NY, USA, 1974. View at Google Scholar
  27. W. A. Marshall, “Interrelationships of skeletal maturation, sexual development and somatic growth in man,” Annals of Human Biology, vol. 1, no. 1, pp. 29–40, 1974. View at Publisher · View at Google Scholar · View at Scopus
  28. J. J. Trueta, “The growth and development of bones and joints: orthopedic aspects,” in Scientific Foundation of Pediatrics, J. Davis and J. Dobbing, Eds., pp. 399–419, W.B. Saunders, Philadelphia, Pa, USA, 1974. View at Google Scholar
  29. J. J. van der Werff ten Bosch, “Testosterone as growth stimulant in man,” Pharmacology and Therapeutics, vol. 2, no. 1, pp. 17–32, 1977. View at Publisher · View at Google Scholar · View at Scopus
  30. J. S. Finkelstein, A. Klibanski, R. M. Neer, S. L. Greenspan, D. I. Rosenthal, and W. F. Crowley Jr., “Osteoporosis in men with idiopathic hypogonadotropic hypogonadism,” Annals of Internal Medicine, vol. 106, no. 3, pp. 354–361, 1987. View at Publisher · View at Google Scholar · View at Scopus
  31. J. S. Finkelstein, R. M. Neer, B. M. K. Biller, J. D. Crawford, and A. Klibanski, “Osteopenia in men with a history of delayed puberty,” The New England Journal of Medicine, vol. 326, no. 9, pp. 600–604, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. J. S. van den Bosch, A. G. H. Smals, G. F. F. M. Pieters, I. M. Valk, and P. W. Kloppenborg, “Instant growth inhibition by low dose oestrogens in excessively tall boys,” Acta Endocrinologica, vol. 100, no. 3, pp. 327–332, 1982. View at Google Scholar · View at Scopus
  33. M. Caruso-Nicoletti, F. Cassorla, M. Skerda, J. L. Ross, D. L. Loriaux, and G. B. Cutler Jr., “Short term, low dose estradiol accelerates ulnar growth in boys,” The Journal of Clinical Endocrinology and Metabolism, vol. 61, no. 5, pp. 896–898, 1985. View at Publisher · View at Google Scholar · View at Scopus
  34. G. B. Cutler Jr., F. G. Cassorla, J. L. Ross et al., “Pubertal growth: physiology and pathophysiology,” Recent Progress in Hormone Research, vol. 42, pp. 443–470, 1986. View at Google Scholar · View at Scopus
  35. P. A. Lee and S. F. Witchel, “The influence of estrogen on growth,” Current Opinion in Pediatrics, vol. 9, no. 4, pp. 431–436, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. E. P. Smith, J. Boyd, G. R. Frank et al., “Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man,” The New England Journal of Medicine, vol. 331, no. 16, pp. 1056–1061, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Morishima, M. M. Grumbach, E. R. Simpson, C. Fisher, and K. Qin, “Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 12, pp. 3689–3698, 1995. View at Google Scholar · View at Scopus
  38. C. Carani, K. Qin, M. Simoni et al., “Effect of testosterone and estradiol in a man with aromatase deficiency,” The New England Journal of Medicine, vol. 337, no. 2, pp. 91–95, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. J. P. Bilezikian, A. Morishima, J. Bell, and M. M. Grumbach, “Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency,” The New England Journal of Medicine, vol. 339, no. 9, pp. 599–603, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Rochira and C. Carani, “Aromatase deficiency in men: a clinical perspective,” Nature Reviews Endocrinology, vol. 5, no. 10, pp. 559–568, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Bouillon, M. Bex, D. Vanderschueren, and S. Boonen, “Estrogens are essential for male pubertal periosteal bone expansion,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 12, pp. 6025–6029, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. B. L. Herrmann, B. Saller, O. E. Janssen et al., “Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 12, pp. 5476–5484, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Maffei, Y. Murata, V. Rochira et al., “Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 1, pp. 61–70, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Maffei, V. Rochira, L. Zirilli et al., “A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome,” Clinical Endocrinology, vol. 67, no. 2, pp. 218–224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Lanfranco, L. Zirilli, M. Baldi et al., “A novel mutation in the human aromatase gene: Insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment,” Bone, vol. 43, no. 3, pp. 628–635, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Pignatti, K. Unluhizarci, E. Kartal et al., “Complete aromatase deficiency in four adult men: detection of a novel mutation and two known mutations in the CYP19A1 gene,” Endocrine Abstracts, vol. 32, p. 640, 2013. View at Google Scholar
  47. L. Zirilli, V. Rochira, C. Diazzi, G. Caffagni, and C. Carani, “Human models of aromatase deficiency,” Journal of Steroid Biochemistry and Molecular Biology, vol. 109, no. 3–5, pp. 212–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Vandewalle, Y. Taes, M. van Helvoirt et al., “Bone size and bone strength are increased in obese male adolescents,” The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 7, pp. 3019–3028, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Weise, S. De-Levi, K. M. Barnes, R. I. Gafni, V. Abad, and J. Baron, “Effects of estrogen on growth plate senescence and epiphyseal fusion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 12, pp. 6871–6876, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. O. Nilsson, M. Weise, E. B. Landman, I. L. Meyers, K. M. Barnes, and J. Baron, “Evidence that estrogen hastens epiphyseal fusion and cessation of longitudinal bone growth by irreversibly depleting the number of resting zone progenitor cells in female rabbits,” Endocrinology, vol. 155, no. 8, pp. 2892–2899, 2014. View at Google Scholar
  51. V. Kusec, A. S. Virdi, R. Prince, and J. T. Triffitt, “Localization of estrogen receptor-α in human and rabbit skeletal tissues,” The Journal of Clinical Endocrinology & Metabolism, vol. 83, no. 7, pp. 2421–2428, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. L. O. Nilsson, A. Boman, L. Sävendahl et al., “Demonstration of estrogen receptor-β immunoreactivity in human growth plate cartilage,” The Journal of Clinical Endocrinology & Metabolism, vol. 84, no. 1, pp. 370–373, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. A. S. Chagin and L. Sävendahl, “Brief report: GPR30 estrogen receptor expression in the growth plate declines as puberty progresses,” The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 12, pp. 4873–4877, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. O. K. Oz, R. Millsaps, R. Welch, J. Birch, and J. E. Zerwekh, “Expression of aromatase in the human growth plate,” Journal of Molecular Endocrinology, vol. 27, no. 2, pp. 249–253, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. V. L. Sylvia, I. Gay, R. Hardin, D. D. Dean, B. D. Boyan, and Z. Schwartz, “Rat costochondral chondrocytes produce 17β-estradiol and regulate its production by 1α,25(OH)2D3,” Bone, vol. 30, no. 1, pp. 57–63, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. B. C. J. van der Eerden, J. D. E. van Ven, C. W. G. M. Lowik, J. M. Wit, and M. Karperien, “Sex steroid metabolism in the tibial growth plate of the rat,” Endocrinology, vol. 143, no. 10, pp. 4048–4055, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. A. S. Chagin, D. Chrysis, M. Takigawa, E. M. Ritzen, and L. Sävendahl, “Locally produced estrogen promotes fetal rat metatarsal bone growth; an effect mediated through increased chondrocyte proliferation and decreased apoptosis,” Journal of Endocrinology, vol. 188, no. 2, pp. 193–203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. S. H. Windahl, N. Andersson, A. S. Chagin et al., “The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice,” American Journal of Physiology—Endocrinology and Metabolism, vol. 296, no. 3, pp. E490–E496, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. A. E. Börjesson, M. K. Lagerquist, S. H. Windahl, and C. Ohlsson, “The role of estrogen receptor α in the regulation of bone and growth plate cartilage,” Cellular and Molecular Life Sciences, vol. 70, no. 21, pp. 4023–4037, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. A. S. Chagin, M. K. Lindberg, N. Andersson et al., “Estrogen receptor-β inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice,” Journal of Bone and Mineral Research, vol. 19, no. 1, pp. 72–77, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. E. P. Smith, B. Specker, B. E. Bachrach et al., “Impact on bone of an estrogen receptor-α gene loss of function mutation,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 8, pp. 3088–3096, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. E. P. Smith, B. Specker, and K. S. Korach, “Recent experimental and clinical findings in the skeleton associated with loss of estrogen hormone or estrogen receptor activity,” Journal of Steroid Biochemistry and Molecular Biology, vol. 118, no. 4-5, pp. 264–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. A. S. Chagin and L. Sävendahl, “Oestrogen receptors and linear bone growth,” Acta Paediatrica, vol. 96, no. 9, pp. 1275–1279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. J. D. Veldhuis, J. N. Roemmich, E. J. Richmond et al., “Endocrine control of body composition in infancy, childhood, and puberty,” Endocrine Reviews, vol. 26, no. 1, pp. 114–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. V. Rochira, L. Zirilli, L. Maffei et al., “Tall stature without growth hormone: four male patients with aromatase deficiency,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 4, pp. 1626–1633, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. D. L. Metzger and J. R. Kerrigan, “Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence,” The Journal of Clinical Endocrinology & Metabolism, vol. 79, no. 2, pp. 513–518, 1994. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Hero, E. Norjavaara, and L. Dunkel, “Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 12, pp. 6396–6402, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. O. Nilsson, D. Chrysis, O. Pajulo et al., “Localization of estrogen receptors-α and -β and androgen receptor in the human growth plate at different pubertal stages,” Journal of Endocrinology, vol. 177, no. 2, pp. 319–326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. S. G. Ren, S. Malozowski, P. Sanchez, D. E. Seet, D. L. Loriaux, and F. Cassorla, “Direct administration of testosterone increases rat tibial epiphyseal growth plate width,” Acta Endocrinologica, vol. 121, no. 3, pp. 401–405, 1989. View at Google Scholar · View at Scopus
  70. E. Nieschlag and H. Behre, “Clinical use of testosterone in hypogonadism and other conditions,” in Testosterone: Action, Deficiency, Substitution, E. Nieschlag and H. Behre, Eds., chapter 14, pp. 292–308, Cambridge University Press, Cambridge, UK, 4th edition, 2012. View at Google Scholar
  71. M. Zachmann, A. Prader, E. H. Sobel et al., “Pubertal growth in patients with androgen insensitivity: indirect evidence for the importance of estrogens in pubertal growth of girls,” The Journal of Pediatrics, vol. 108, no. 5, pp. 694–697, 1986. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Taes, B. Lapauw, S. Vandewalle et al., “Estrogen-specific action on bone geometry and volumetric bone density: longitudinal observations in an adult with complete androgen insensitivity,” Bone, vol. 45, no. 2, pp. 392–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Trabado, L. Maione, S. Salenave et al., “Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment,” Fertility and Sterility, vol. 95, no. 7, pp. 2324–2329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. V. Rochira, A. Balestrieri, B. Madeo, L. Zirilli, A. R. M. Granata, and C. Carani, “Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho) physiology,” European Journal of Endocrinology, vol. 154, no. 2, pp. 175–185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Laurent, L. Antonio, M. Sinnesael et al., “Androgens and estrogens in skeletal sexual dimorphism,” Asian Journal of Andrology, vol. 16, no. 2, pp. 213–222, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. J.-P. Bonjour, G. Theintz, B. Buchs, D. Slosman, and R. Rizzoli, “Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence,” The Journal of Clinical Endocrinology and Metabolism, vol. 73, no. 3, pp. 555–563, 1991. View at Publisher · View at Google Scholar · View at Scopus
  77. D. Vanderschueren, M. R. Laurent, F. Claessens et al., “Sex steroid actions in male bone,” Endocrine Reviews, 2014. View at Publisher · View at Google Scholar
  78. L. Vico and J.-M. Vanacker, “Sex hormones and their receptors in bone homeostasis: insights from genetically modified mouse models,” Osteoporosis International, vol. 21, no. 3, pp. 365–372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. F. Callewaert, S. Boonen, and D. Vanderschueren, “Sex steroids and the male skeleton: a tale of two hormones,” Trends in Endocrinology and Metabolism, vol. 21, no. 2, pp. 89–95, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Fukami, M. Shozu, and T. Ogata, “Molecular bases and phenotypic determinants of aromatase excess syndrome,” International Journal of Endocrinology, vol. 2012, Article ID 584807, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. D. Yilmaz, B. Ersoy, E. Bilgin, G. Gümüşer, E. Onur, and E. D. Pinar, “Bone mineral density in girls and boys at different pubertal stages: relation with gonadal steroids, bone formation markers, and growth parameters,” Journal of Bone and Mineral Metabolism, vol. 23, no. 6, pp. 476–482, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. B. M. Lapauw, Y. Taes, V. Bogaert et al., “Serum estradiol is associated with volumetric BMD and modulates the impact of physical activity on bone size at the age of peak bone mass: a study in healthy male siblings,” Journal of Bone and Mineral Research, vol. 24, no. 6, pp. 1075–1085, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. B. L. Riggs, S. Khosla, and L. J. Melton III, “Sex steroids and the construction and conservation of the adult skeleton,” Endocrine Reviews, vol. 23, no. 3, pp. 279–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Khosla, M. J. Oursler, and D. G. Monroe, “Estrogen and the skeleton,” Trends in Endocrinology and Metabolism, vol. 23, no. 11, pp. 576–581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. S. C. Manolagas, C. A. O'Brien, and M. Almeida, “The role of estrogen and androgen receptors in bone health and disease,” Nature Reviews Endocrinology, vol. 9, no. 12, pp. 699–712, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Tomkinson, E. F. Gevers, J. M. Wit, J. Reeve, and B. S. Noble, “The role of estrogen in the control of rat osteocyte apoptosis,” Journal of Bone and Mineral Research, vol. 13, no. 8, pp. 1243–1250, 1998. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Kousteni, T. Bellido, L. I. Plotkin et al., “Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity,” Cell, vol. 104, no. 5, pp. 719–730, 2001. View at Google Scholar · View at Scopus
  88. S. Khosla, L. J. Melton III, and B. L. Riggs, “The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?” Journal of Bone and Mineral Research, vol. 26, no. 3, pp. 441–451, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Khosla, “Update on estrogens and the skeleton,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 8, pp. 3569–3577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Idan, K. A. Griffiths, D. T. Harwood et al., “Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial,” Annals of Internal Medicine, vol. 153, no. 10, pp. 621–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Falahati-Nini, B. L. Riggs, E. J. Atkinson, W. M. O'Fallon, R. Eastell, and S. Khosla, “Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men,” The Journal of Clinical Investigation, vol. 106, no. 12, pp. 1553–1560, 2000. View at Publisher · View at Google Scholar · View at Scopus
  92. G. A. Greendale, S. Edelstein, and E. Barrett-Connor, “Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study,” Journal of Bone and Mineral Research, vol. 12, no. 11, pp. 1833–1843, 1997. View at Publisher · View at Google Scholar · View at Scopus
  93. C. W. Slemenda, C. Longcope, L. Zhou, S. L. Hui, M. Peacock, and C. C. Johnston, “Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens,” The Journal of Clinical Investigation, vol. 100, no. 7, pp. 1755–1759, 1997. View at Publisher · View at Google Scholar · View at Scopus
  94. S. Amin, Y. Zhang, C. T. Sawin et al., “Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study,” Annals of Internal Medicine, vol. 133, no. 12, pp. 951–963, 2000. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Khosla, L. J. Melton III, E. J. Atkinson, and W. M. O'Fallon, “Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 8, pp. 3555–3561, 2001. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Szulc, F. Munoz, B. Claustrat et al., “Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 1, pp. 192–199, 2001. View at Publisher · View at Google Scholar · View at Scopus
  97. K. E. Ensrud, C. E. Lewis, L. C. Lambert et al., “Endogenous sex steroids, weight change and rates of hip bone loss in older men: the MrOS study,” Osteoporosis International, vol. 17, no. 9, pp. 1329–1336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. K. A. Ward, S. R. Pye, J. E. Adams et al., “Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men,” Osteoporosis International, vol. 22, no. 5, pp. 1513–1523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. E. Barrett-Connor, J. E. Mueller, D. G. von Mühlen, G. A. Laughlin, D. L. Schneider, and D. J. Sartoris, “Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 1, pp. 219–223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  100. H. W. Goderie-Plomp, M. van der Klift, W. de Ronde, A. Hofman, F. H. de Jong, and H. A. P. Pols, “Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam study,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 7, pp. 3261–3269, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Amin, Y. Zhang, D. T. Felson et al., “Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study,” The American Journal of Medicine, vol. 119, no. 5, pp. 426–433, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. D. Mellström, L. Vandenput, H. Mallmin et al., “Older men with low serum estradiol and high serum SHBG have an increased risk of fractures,” Journal of Bone and Mineral Research, vol. 23, no. 10, pp. 1552–1560, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Reutrakul, B. Ongphiphadhanakul, N. Piaseu et al., “The effects of oestrogen exposure on bone mass in male to female transsexuals,” Clinical Endocrinology, vol. 49, no. 6, pp. 811–814, 1998. View at Publisher · View at Google Scholar · View at Scopus
  104. P. van Kesteren, P. Lips, L. J. G. Gooren, H. Asscheman, and J. Megens, “Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones,” Clinical Endocrinology, vol. 48, no. 3, pp. 347–354, 1998. View at Publisher · View at Google Scholar · View at Scopus
  105. A. Mueller, R. Dittrich, H. Binder et al., “High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone,” European Journal of Endocrinology, vol. 153, no. 1, pp. 107–113, 2005. View at Publisher · View at Google Scholar · View at Scopus
  106. K. Carlström, R. Stege, P. Henriksson, M. Grande, P. O. Gunnarsson, and A. Pousette, “Possible bone-preserving capacity of high-dose intramuscular depot estrogen as compared to orchidectomy in the treatment of patients with prostatic carcinoma,” Prostate, vol. 31, no. 3, pp. 193–197, 1997. View at Google Scholar
  107. P. Taxel, D. G. Kennedy, P. M. Fall, A. K. Willard, J. M. Clive, and L. G. Raisz, “The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 6, pp. 2869–2874, 2001. View at Publisher · View at Google Scholar · View at Scopus
  108. S.-A. M. Burnett-Bowie, E. A. McKay, H. Lee, and B. Z. Leder, “Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 12, pp. 4785–4792, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. B. Ongphiphadhanakul, R. Rajatanavin, S. Chanprasertyothin, N. Piaseu, and L. Chailurkit, “Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males,” Clinical Endocrinology, vol. 49, no. 6, pp. 803–809, 1998. View at Publisher · View at Google Scholar · View at Scopus
  110. S. Khosla, B. L. Riggs, E. J. Atkinson et al., “Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 4, pp. 1808–1816, 2004. View at Publisher · View at Google Scholar · View at Scopus
  111. I. van Pottelbergh, S. Goemaere, and J. M. Kaufman, “Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 7, pp. 3075–3081, 2003. View at Publisher · View at Google Scholar · View at Scopus
  112. L. Gennari, L. Masi, D. Merlotti et al., “A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2803–2810, 2004. View at Publisher · View at Google Scholar · View at Scopus
  113. V. Rochira, M. Faustini-Fustini, A. Balestrieri, and C. Carani, “Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters,” The Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 5, pp. 1841–1845, 2000. View at Publisher · View at Google Scholar · View at Scopus
  114. V. Rochira, L. Zirilli, B. Madeo et al., “Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone,” Bone, vol. 40, no. 6, pp. 1662–1668, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. L. Vandenput and C. Ohlsson, “Sex steroid metabolism in the regulation of bone health in men,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 121, no. 3–5, pp. 582–588, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Khosla, “Estrogen and bone: Insights from estrogen-resistant, aromatase-deficient, and normal men,” Bone, vol. 43, no. 3, pp. 414–417, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. E. Seeman, “From density to structure: growing up and growing old on the surfaces of bone,” Journal of Bone and Mineral Research, vol. 12, no. 4, pp. 509–521, 1997. View at Publisher · View at Google Scholar · View at Scopus
  118. E. Seeman and P. D. Delmas, “Bone quality—the material and structural basis of bone strength and fragility,” The New England Journal of Medicine, vol. 354, no. 21, pp. 2250–2261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  119. C. Ohlsson, A. Darelid, M. Nilsson, J. Melin, D. Mellström, and M. Lorentzon, “Cortical consolidation due to increased mineralization and endosteal contraction in young adult men: a five-year longitudinal study,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. 2262–2269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Darelid, C. Ohlsson, M. Nilsson, J. M. Kindblom, D. Mellström, and M. Lorentzon, “Catch up in bone acquisition in young adult men with late normal puberty,” Journal of Bone and Mineral Research, vol. 27, no. 10, pp. 2198–2207, 2012. View at Publisher · View at Google Scholar · View at Scopus
  121. J. S. Walsh, M. A. Paggiosi, and R. Eastell, “Cortical consolidation of the radius and tibia in young men and women,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 9, pp. 3342–3348, 2012. View at Publisher · View at Google Scholar · View at Scopus
  122. S. Bhasin, R. Jasuja, C. Serra et al., “Androgen effects on the skeletal muscle,” in Testosterone, Action, Deficiency, Substitution, E. Nieschlag and H. Behre, Eds., vol. 14, Chapter 14, pp. 191–206, Cambridge University Press, Cambridge, UK, 4th edition, 2012. View at Google Scholar
  123. F. Rauch, D. A. Bailey, A. Baxter-Jones, R. Mirwald, and R. Faulkner, “The “muscle-bone unit” during the pubertal growth spurt,” Bone, vol. 34, no. 5, pp. 771–775, 2004. View at Publisher · View at Google Scholar · View at Scopus
  124. E. van Caenegem, K. Wierckx, Y. Taes et al., “Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy,” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 7, pp. 2503–2511, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. D. Vanderschueren, K. Venken, J. Ophoff, R. Bouillon, and S. Boonen, “Clinical review: Sex steroids and the periosteum—reconsidering the roles of androgens and estrogens in periosteal expansion,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 2, pp. 378–382, 2006. View at Publisher · View at Google Scholar · View at Scopus
  126. D. L. S. Danilovic, P. H. S. Correa, E. M. F. Costa, K. F. S. Melo, B. B. Mendonca, and I. J. P. Arnhold, “Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene,” Osteoporosis International, vol. 18, no. 3, pp. 369–374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. T. S. Han, D. Goswami, S. Trikudanathan, S. M. Creighton, and G. S. Conway, “Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis,” European Journal of Endocrinology, vol. 159, no. 2, pp. 179–185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. L. Vandenput, J. V. Swinnen, S. Boonen et al., “Role of the androgen receptor in skeletal homeostasis: the androgen-resistant testicular feminized male mouse model,” Journal of Bone and Mineral Research, vol. 19, no. 9, pp. 1462–1470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  129. F. C. W. Wu, A. Tajar, J. M. Beynon et al., “Identification of late-onset hypogonadism in middle-aged and elderly men,” The New England Journal of Medicine, vol. 363, no. 2, pp. 123–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. G. Sartorius, S. Spasevska, A. Idan et al., “Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study,” Clinical Endocrinology, vol. 77, no. 5, pp. 755–763, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. L. Vandenput, M. Lorentzon, D. Sundh et al., “Serum estradiol levels are inversely associated with cortical porosity in older men,” The Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 7, pp. E1322–E1326, 2014. View at Google Scholar
  132. V. Rochira, A. Balestrieri, B. Madeo, L. Zirilli, A. R. Granata, and C. Carani, “Bone loss, sex steroids and male age related hypogonadism,” Journal of Endocrinological Investigation, vol. 28, no. 11, pp. 46–48, 2005. View at Google Scholar · View at Scopus
  133. E. Orwoll, L. C. Lambert, L. M. Marshall et al., “Endogenous testosterone levels, physical performance, and fall risk in older men,” Archives of Internal Medicine, vol. 166, no. 19, pp. 2124–2131, 2006. View at Publisher · View at Google Scholar · View at Scopus
  134. L. Zirilli, L. Maffei, P. J. Meunier, P. Chavassieux, C. Carani, and V. Rochira, “The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency,” Bone, vol. 45, no. 5, pp. 827–832, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. A. S. Chagin, E. Karimian, F. Zaman, M. Takigawa, D. Chrysis, and L. Sävendahl, “Tamoxifen induces permanent growth arrest through selective induction of apoptosis in growth plate chondrocytes in cultured rat metatarsal bones,” Bone, vol. 40, no. 5, pp. 1415–1424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  136. P. M. Doran, B. L. Riggs, E. J. Atkinson, and S. Khosla, “Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men,” Journal of Bone and Mineral Research, vol. 16, no. 11, pp. 2118–2125, 2001. View at Publisher · View at Google Scholar · View at Scopus
  137. M. R. Smith, M. A. Fallon, H. Lee, and J. S. Finkelstein, “Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 8, pp. 3841–3846, 2004. View at Publisher · View at Google Scholar · View at Scopus
  138. N. Mauras, L. G. de Pijem, H. Y. Hsiang et al., “Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 3, pp. 823–831, 2008. View at Publisher · View at Google Scholar · View at Scopus
  139. P. E. Løning and H. P. Eikesdal, “Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved,” Endocrine-Related Cancer, vol. 20, no. 4, pp. R183–R201, 2013. View at Publisher · View at Google Scholar · View at Scopus
  140. M. Hero, O. Mäkitie, H. Kröger, E. Nousiainen, S. Toiviainen-Salo, and L. Dunkel, “Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature,” Hormone Research, vol. 71, no. 5, pp. 290–297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  141. V. Rochira, “Aromatase inhibitors in pubertal boys: clinical implications,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 4, pp. 1836–1838, 2001. View at Publisher · View at Google Scholar · View at Scopus
  142. M. E. Geffner, “Aromatase inhibitors to augment height: continued caution and study required,” Journal of Clinical Research in Pediatric Endocrinology, vol. 1, no. 6, pp. 256–261, 2009. View at Publisher · View at Google Scholar · View at Scopus
  143. W. Rosner, S. E. Hankinson, P. M. Sluss, H. W. Vesper, and M. E. Wierman, “Challenges to the measurement of estradiol: an endocrine society position statement,” The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 4, pp. 1376–1387, 2013. View at Publisher · View at Google Scholar · View at Scopus
  144. B. Madeo, L. Zirilli, G. Caffagni et al., “The osteoporotic male: overlooked and undermanaged?” Clinical Interventions in Aging, vol. 2, no. 3, pp. 305–312, 2007. View at Google Scholar · View at Scopus
  145. S. Basaria, A. D. Coviello, T. G. Travison et al., “Adverse events associated with testosterone administration,” The New England Journal of Medicine, vol. 363, no. 2, pp. 109–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  146. R. Vigen, C. I. O'Donnell, A. E. Barón et al., “Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels,” The Journal of the American Medical Association, vol. 310, no. 17, pp. 1829–1836, 2013. View at Publisher · View at Google Scholar · View at Scopus
  147. J. M. Kaufman, “Mortality associated to late-onset hypogonadism: reasons not to treat with testosterone?” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 4, pp. 1161–1163, 2014. View at Publisher · View at Google Scholar · View at Scopus
  148. E. Hernlund, A. Svedbom, M. Ivergård et al., “Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA),” Archives of Osteoporosis, vol. 8, no. 1-2, article 136, 2013. View at Publisher · View at Google Scholar · View at Scopus